Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS)
600566.SS on Shanghai Stock Exchange
32.63CNY
24 May 2019
32.63CNY
24 May 2019
Change (% chg)
¥0.03 (+0.09%)
¥0.03 (+0.09%)
Prev Close
¥32.60
¥32.60
Open
¥32.57
¥32.57
Day's High
¥32.86
¥32.86
Day's Low
¥32.40
¥32.40
Volume
3,326,328
3,326,328
Avg. Vol
7,713,565
7,713,565
52-wk High
¥54.97
¥54.97
52-wk Low
¥28.53
¥28.53
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 2,079.42 | 0.626 |
| FY 2018 | Dec '18 | 1,664.22 | 0.465 |
| Sep '18 | 1,740.26 | 0.570 | |
| Jun '18 | 1,676.12 | 0.464 | |
| Mar '18 | 2,127.61 | 0.574 | |
| FY 2017 | Dec '17 | 1,428.39 | 0.390 |
| Sep '17 | 1,403.45 | 0.402 | |
| Jun '17 | 1,405.36 | 0.360 | |
| Mar '17 | 1,404.81 | 0.359 |
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-19 | 5 | 8,565.15 | 8,724.00 | 8,295.00 | 8,691.12 |
| Year Ending Dec-20 | 5 | 10,255.40 | 10,600.00 | 9,918.00 | 10,329.90 |
| Earnings (per share) | |||||
| Year Ending Dec-19 | 5 | 2.52 | 2.60 | 2.46 | 2.49 |
| Year Ending Dec-20 | 5 | 3.12 | 3.24 | 3.00 | 3.16 |
Sales and Profit Figures in China Yuan Renminbi (CNY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 15.34 | 31.10 | 35.45 | |
| P/E High - Last 5 Yrs. | 31.48 | 50.30 | 57.53 | |
| P/E Low - Last 5 Yrs. | 16.19 | 27.14 | 28.17 | |
| Beta | 0.49 | 0.96 | 0.95 | |
| Price to Sales (TTM) | 3.71 | 7.49 | 9.26 | |
| Price to Book (MRQ) | 4.45 | 3.57 | 4.16 | |
| Price to Tangible Book (MRQ) | 4.84 | 3.86 | 4.94 | |
| Price to Cash Flow (TTM) | -- | 22.32 | 24.35 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 3.07 | 1.83 | 1.66 | |
| Dividend Yield - 5 Year Avg | 2.70 | 0.73 | 0.72 | |
| Dividend 5 Year Growth Rate | -- | 2.29 | 3.10 | |
| Payout Ratio(TTM) | 57.90 | 15.88 | 15.26 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -2.26 | 14.98 | 16.47 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 12.49 | 6.25 | 8.16 | |
| Sales - 5 Yr. Growth Rate | 24.11 | 9.20 | 10.32 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 9.07 | 19.30 | 19.77 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 23.12 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 25.73 | 5.66 | 7.24 | |
| Capital Spending - 5 Yr. Growth Rate | 19.86 | 7.30 | 8.28 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.48 | 2.42 | 2.43 |
| Current Ratio (MRQ) | 2.64 | 3.38 | 3.37 |
| LT Debt to Equity (MRQ) | 9.31 | 13.53 | 14.38 |
| Total Debt to Equity (MRQ) | 9.31 | 18.41 | 19.78 |
| Interest Coverage (TTM) | -- | 7.75 | 13.44 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 83.25 | 51.82 | 50.28 | |
| Gross Margin - 5 Yr. Avg. | 84.67 | 50.56 | 51.33 | |
| EBITD Margin (TTM) | 26.75 | -- | -- | |
| EBITD - 5 Yr. Avg | 25.48 | 17.44 | 15.88 | |
| Operating Margin (TTM) | 26.99 | 1.18 | -4.40 | |
| Operating Margin - 5 Yr. Avg. | 23.53 | 13.61 | 11.12 | |
| Pre-Tax Margin (TTM) | 28.38 | 0.72 | -4.77 | |
| Pre-Tax Margin - 5 Yr. Avg. | 24.32 | 19.54 | 16.00 | |
| Net Profit Margin (TTM) | 24.18 | -2.93 | -8.54 | |
| Net Profit Margin - 5 Yr. Avg. | 20.79 | 14.69 | 11.23 | |
| Effective Tax Rate (TTM) | 14.80 | 19.52 | 19.91 | |
| Effective Tax Rate - 5 Yr. Avg. | 14.49 | 22.55 | 24.16 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 1,002,102 | 882,514,747 | 746,078,341 | |
| Net Income/Employee (TTM) | 242,296 | 103,076,479 | 87,169,841 | |
| Receivable Turnover (TTM) | 3.30 | 5.38 | 5.69 | |
| Inventory Turnover (TTM) | 4.84 | 2.50 | 3.64 | |
| Asset Turnover (TTM) | 0.89 | 0.82 | 0.79 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 21.63 | 9.72 | 9.46 | |
| Return on Assets - 5 Yr. Avg. | 21.48 | 10.96 | 10.47 | |
| Return on Investment (TTM) | 28.15 | 12.04 | 11.75 | |
| Return on Investment - 5 Yr. Avg. | 28.73 | 13.95 | 13.33 | |
| Return on Equity (TTM) | 31.94 | 13.35 | 16.50 | |
| Return on Equity - 5 Yr. Avg. | 30.94 | 15.25 | 14.89 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 27.76 | 24.14 | 24.11 |
| EPS (TTM) % | 37.08 | 33.10 | 25.73 |
| Dividend % | 23.00 | 20.67 | -- |
Note: Units in Millions of US Dollars
Performance for Hubei Jumpcan Pharmaceutical Co Ltd
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 8.47% |
| # of Holders: | 82 |
| Total Shares Held: | 69,022,548 |
| 3 Mo. Net Change: | 624,969 |
| # New Positions: | 4 |
| # Closed Positions: | 1 |
| # Increased Positions: | 14 |
| # Reduced Positions: | 6 |
| # Net Buyers: | 8 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.